Actinic Keratosis (AK) is a pre-cancerous skin condition caused by long-term exposure to ultraviolet (UV) radiation. It is characterized by scaly, rough patches on the skin that can become cancerous if left untreated. Skin cancer drugs are used to treat AK and prevent it from progressing to a more serious form of skin cancer. These drugs are typically topical creams or ointments that are applied directly to the affected area. They work by slowing down the growth of abnormal cells and preventing them from spreading. The Actinic Keratosis Drug market is a subset of the larger Skin Cancer Drug market. It is composed of a variety of products, including topical creams, ointments, and other treatments. These products are used to treat AK and prevent it from progressing to a more serious form of skin cancer. Some companies in the Actinic Keratosis Drug market include Galderma, Leo Pharma, and Sun Pharmaceuticals. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
